Cancer Treatment Advancements Enabled by Insilico Medicine’s AI-driven Breakthrough
Insilico Medicine Strikes Groundbreaking Deal for Breast Cancer Drug Candidate Insilico Medicine, a leading AI-driven drug discovery firm based in Hong Kong, has made waves in the pharmaceutical industry with its recent deal involving a breast cancer drug candidate. The company has partnered with Italy’s Menarini Group in a transaction that could potentially exceed $500 million. […]
Cancer Treatment Advancements Enabled by Insilico Medicine’s AI-driven Breakthrough Read More ยป